 |
(E)-(6-((N-methyl-((3-methylbenzofuran-2-yl)methyl)amino)-3-oxoprop-1-en-1-yl)-2-oxo-3,4-dihydro-1,8-naphthyridin-1(2H)-yl)methyl phosphate, bis ethanolamine salt |
|---|---|
| Trade Name | |
| Orphan Indication | Osteomyelitis |
| EU Market Approval | EU |
| EU Designation Date | 2016-10-14 00:00:00 |
| Sponsor | Voisin Consulting S.A.R.L. |
